Risk of diarrhea in patients with type 2 diabetes mellitus treated with sitagliptin: a meta-analysis of 30 randomized clinical trials

BACKGROUND: Sitagliptin is an important drug used for diabetes treatment and is used as a monotherapy in diabetic patients. However, there are also reported cases of diarrhea with sitagliptin use. Unfortunately, data concerning the relationship of diarrhea with sitagliptin use in various conditions...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qingwei, Hong, Dongsheng, Zheng, Dongsheng, Xiao, Yao, Wu, Baohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234286/
https://www.ncbi.nlm.nih.gov/pubmed/25419118
http://dx.doi.org/10.2147/DDDT.S70945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234286/
https://www.ncbi.nlm.nih.gov/pubmed/25419118
http://dx.doi.org/10.2147/DDDT.S70945

Ejemplares similares